ResMed Stock Options Expiring on 21st of February
| RMD Stock | USD 247.33 0.46 0.19% |
ResMed's latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 0.51 with a put-to-call open interest ratio of 1.15 over 39 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on February 21st 2025. The total put volume is at 84.0, with calls trading at the volume of 24.0. This yields a 3.5 put-to-call volume ratio.
Open Interest Against February 21st 2025 Option Contracts
2025-02-21
The chart above shows ResMed's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. ResMed's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for ResMed's option, there is no secondary market available for investors to trade.
ResMed Maximum Pain Price Across 2025-02-21 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as ResMed close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, ResMed's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
ResMed's stock options are financial instruments that give investors the right to buy or sell shares of ResMed Inc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell ResMed stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If ResMed's stock price goes up or down, the stock options follow.
At present, ResMed's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 116.6 M, whereas Common Stock Total Equity is forecasted to decline to about 417 K. ResMed Inc In The Money Call Balance
When ResMed's strike price is surpassing the current stock price, the option contract against ResMed Inc stock is said to be in the money. When it comes to buying ResMed's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on ResMed Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
ResMed Current Options Market Mood
ResMed's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps ResMed Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most ResMed's options investors are not very successful. ResMed's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current ResMed contract
Base on the Rule 16, the options market is currently suggesting that ResMed Inc will have an average daily up or down price movement of about 0.0319% per day over the life of the 2025-02-21 option contract. With ResMed trading at USD 247.33, that is roughly USD 0.0788. If you think that the market is fully incorporating ResMed's daily price movement you should consider buying ResMed Inc options at the current volatility level of 0.51%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
ResMed |
ResMed Option Chain
When ResMed's strike price is surpassing the current stock price, the option contract against ResMed Inc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
ResMed's option chain is a display of a range of information that helps investors for ways to trade options on ResMed. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ResMed. It also shows strike prices and maturity days for a ResMed against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | RMD250221C00200000 | 1 | 200.0 | 46.0 - 50.8 | 37.07 | In |
Call | RMD250221C00220000 | 16 | 220.0 | 28.6 - 32.0 | 19.3 | In |
Call | RMD250221C00230000 | 133 | 230.0 | 21.6 - 22.9 | 22.7 | In |
Call | RMD250221C00240000 | 144 | 240.0 | 14.9 - 16.8 | 15.5 | In |
Call | RMD250221C00250000 | 156 | 250.0 | 9.6 - 11.0 | 9.65 | Out |
Call | RMD250221C00260000 | 223 | 260.0 | 5.3 - 6.4 | 6.07 | Out |
Call | RMD250221C00270000 | 171 | 270.0 | 3.3 - 3.9 | 3.51 | Out |
Call | RMD250221C00280000 | 160 | 280.0 | 1.85 - 2.15 | 1.87 | Out |
Call | RMD250221C00290000 | 9 | 290.0 | 0.95 - 1.35 | 1.2 | Out |
Call | RMD250221C00300000 | 2 | 300.0 | 0.55 - 0.8 | 0.75 | Out |
Call | RMD250221C00310000 | 2 | 310.0 | 0.15 - 0.75 | 0.41 | Out |
Call | RMD250221C00320000 | 0 | 320.0 | 0.05 - 0.95 | 0.05 | |
Call | RMD250221C00330000 | 0 | 330.0 | 0.0 - 2.3 | 2.3 | |
Call | RMD250221C00340000 | 0 | 340.0 | 0.0 - 0.75 | 0.75 | |
Call | RMD250221C00350000 | 0 | 350.0 | 0.0 - 2.2 | 2.2 | |
Call | RMD250221C00360000 | 0 | 360.0 | 0.0 - 0.75 | 0.75 | |
Put | RMD250221P00165000 | 1 | 165.0 | 0.0 - 2.3 | 0.3 | Out |
Put | RMD250221P00170000 | 3 | 170.0 | 0.05 - 2.35 | 0.33 | Out |
Put | RMD250221P00175000 | 8 | 175.0 | 0.0 - 2.4 | 0.25 | Out |
Put | RMD250221P00180000 | 12 | 180.0 | 0.1 - 0.75 | 0.5 | Out |
Put | RMD250221P00185000 | 2 | 185.0 | 0.15 - 0.85 | 0.36 | Out |
Put | RMD250221P00190000 | 17 | 190.0 | 0.2 - 0.75 | 0.53 | Out |
Put | RMD250221P00195000 | 13 | 195.0 | 0.45 - 0.85 | 0.65 | Out |
Put | RMD250221P00200000 | 172 | 200.0 | 0.65 - 0.95 | 0.87 | Out |
Put | RMD250221P00210000 | 481 | 210.0 | 1.2 - 1.65 | 1.48 | Out |
Put | RMD250221P00220000 | 227 | 220.0 | 2.3 - 2.85 | 2.4 | Out |
Put | RMD250221P00230000 | 88 | 230.0 | 4.3 - 5.0 | 4.7 | Out |
Put | RMD250221P00240000 | 31 | 240.0 | 5.7 - 8.1 | 7.51 | Out |
Put | RMD250221P00250000 | 109 | 250.0 | 11.9 - 12.7 | 11.5 | In |
Put | RMD250221P00270000 | 0 | 270.0 | 24.0 - 27.9 | 32.25 | In |
Put | RMD250221P00280000 | 1 | 280.0 | 32.7 - 35.8 | 33.75 | In |
Put | RMD250221P00290000 | 1 | 290.0 | 41.6 - 44.8 | 42.75 | In |
Put | RMD250221P00300000 | 0 | 300.0 | 50.7 - 55.5 | 50.7 | In |
Put | RMD250221P00310000 | 0 | 310.0 | 60.5 - 65.4 | 60.5 | In |
Put | RMD250221P00320000 | 0 | 320.0 | 70.2 - 75.0 | 70.2 | In |
Put | RMD250221P00330000 | 0 | 330.0 | 80.4 - 85.0 | 80.4 | In |
Put | RMD250221P00340000 | 0 | 340.0 | 90.4 - 95.0 | 90.4 | In |
Put | RMD250221P00350000 | 0 | 350.0 | 100.4 - 105.0 | 100.4 | In |
Put | RMD250221P00360000 | 0 | 360.0 | 110.4 - 115.0 | 110.4 | In |
ResMed Total Stockholder Equity
Total Stockholder Equity |
|
ResMed Corporate Directors
| Ronald Taylor | Lead Independent Director | Profile | |
| Harjit Gill | Independent Director | Profile | |
| Carol Burt | Independent Director | Profile | |
| Jan Witte | Independent Director | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.416 | Dividend Share 1.97 | Earnings Share 7.54 | Revenue Per Share | Quarterly Revenue Growth 0.111 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.